Journal of Neurodevelopmental Disorders (Apr 2021)

FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring

  • Reymundo Lozano,
  • Catherine Gbekie,
  • Paige M. Siper,
  • Shubhika Srivastava,
  • Jeffrey M. Saland,
  • Swathi Sethuram,
  • Lara Tang,
  • Elodie Drapeau,
  • Yitzchak Frank,
  • Joseph D. Buxbaum,
  • Alexander Kolevzon

DOI
https://doi.org/10.1186/s11689-021-09358-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Abstract FOXP1 syndrome is a neurodevelopmental disorder caused by mutations or deletions that disrupt the forkhead box protein 1 (FOXP1) gene, which encodes a transcription factor important for the early development of many organ systems, including the brain. Numerous clinical studies have elucidated the role of FOXP1 in neurodevelopment and have characterized a phenotype. FOXP1 syndrome is associated with intellectual disability, language deficits, autism spectrum disorder, hypotonia, and congenital anomalies, including mild dysmorphic features, and brain, cardiac, and urogenital abnormalities. Here, we present a review of human studies summarizing the clinical features of individuals with FOXP1 syndrome and enlist a multidisciplinary group of clinicians (pediatrics, genetics, psychiatry, neurology, cardiology, endocrinology, nephrology, and psychology) to provide recommendations for the assessment of FOXP1 syndrome.

Keywords